Figure 3.
Figure 3. CCR5 deficiency does not affect the proportions of Tregs in the periphery, the suppressive function of Tregs, FoxP3 expression, proliferation, or survival. (A) CD4+CD25+ T cells in spleens, and inguinal (ILNs) and mesenteric lymph nodes (MLNs) from male WT and CCR5-/- mice. Shown are cells within the live lymphocyte gate. Data are representative of 2 organs per group. (B) Suppression of WT responder cell proliferation in response to B6D2 alloantigen by WT (▪) and CCR5-/- (▨) Tregs was assessed as described in “Materials and methods.” Data represent mean ± SEM. *P ≤ .05. (C) FoxP3 expression in WT (▪) and CCR5-/- (▨) Tregs and CD4+CD25-, cultured as described in “Materials and methods,” was assessed by QPCR. Data represent mean ± SEM.

CCR5 deficiency does not affect the proportions of Tregs in the periphery, the suppressive function of Tregs, FoxP3 expression, proliferation, or survival. (A) CD4+CD25+ T cells in spleens, and inguinal (ILNs) and mesenteric lymph nodes (MLNs) from male WT and CCR5-/- mice. Shown are cells within the live lymphocyte gate. Data are representative of 2 organs per group. (B) Suppression of WT responder cell proliferation in response to B6D2 alloantigen by WT (▪) and CCR5-/- (▨) Tregs was assessed as described in “Materials and methods.” Data represent mean ± SEM. *P ≤ .05. (C) FoxP3 expression in WT (▪) and CCR5-/- (▨) Tregs and CD4+CD25-, cultured as described in “Materials and methods,” was assessed by QPCR. Data represent mean ± SEM.

Close Modal

or Create an Account

Close Modal
Close Modal